Skip to main navigation Skip to search Skip to main content

Efficacy and mechanistic study of dual specific inhibitor targeting Integrin αvβ3 and α5β1 against bone metastatic prostate cancer

Project Details

StatusActive
Effective start/end date31/03/24 → 31/12/26

Funding

  • Royal Society: £12,000.00